As on Wednesday, Oncolytics Biotech, Inc (NASDAQ: ONCY) started slowly as it slid -4.03% to $1.19, before settling in for the price of $1.24 at the close. Taking a more long-term approach, ONCY posted a 52-week range of $0.33-$1.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 23.13%. Meanwhile, its Annual Earning per share during the time was 23.13%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 3.87%. This publicly-traded company’s shares outstanding now amounts to $96.60 million, simultaneously with a float of $93.20 million. The organization now has a market capitalization sitting at $114.95 million. At the time of writing, stock’s 50-day Moving Average stood at $0.7102, while the 200-day Moving Average is $0.7982.
Oncolytics Biotech, Inc (ONCY) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Oncolytics Biotech, Inc’s current insider ownership accounts for 3.52%, in contrast to 9.90% institutional ownership.
Oncolytics Biotech, Inc (ONCY) Earnings and Revenue Records
Oncolytics Biotech, Inc’s EPS increase for this current 12-month fiscal period is 3.87% and is forecasted to reach -0.28 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 7.78% through the next 5 years, which can be compared against the 23.13% growth it accomplished over the previous five years trading on the market.
Oncolytics Biotech, Inc (NASDAQ: ONCY) Trading Performance Indicators
Let’s observe the current performance indicators for Oncolytics Biotech, Inc (ONCY). It’s Quick Ratio in the last reported quarter now stands at 3.21.
In the same vein, ONCY’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.29, a figure that is expected to reach -0.07 in the next quarter, and analysts are predicting that it will be -0.28 at the market close of one year from today.
Technical Analysis of Oncolytics Biotech, Inc (ONCY)
Through scrutinizing the latest numbers posted by the [Oncolytics Biotech, Inc, ONCY], it can be observed that its last 5-days Average volume of 0.97 million was lower the volume of 1.0 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 55.91% While, its Average True Range was 59.24%.
Raw Stochastic average of Oncolytics Biotech, Inc (ONCY) in the period of the previous 100 days is set at 84.38%, which indicates a major rise in contrast to 72.41% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.1386 that was higher than 0.0621 volatility it exhibited in the past 100-days period.
